| ID | Name | CAS | Properties |
Inp |
| 30-358-1 |
(3S,4R)-4-Azido-3-tert-butyldimethylsilyloxy-1-tert-butoxycarbonylazepane
|
|
2 | 2084.00 |
| 30-368-0 |
13,14-Dihydro-6,15-diketo-PGF1A, BO-TMS, isomer # 3
|
|
2 | 3178.00 |
| 30-369-9 |
13,14-Dihydro-6,15-diketo-PGF1A, BO-TMS, isomer # 2
|
|
2 | 3173.00 |
| 30-453-5 |
Mannonic acid, 2,3,4,6-tetrakis-O-(trimethylsilyl)-, lactone
|
55515-28-1 |
2 | 1912.00 |
| 30-484-1 |
3«alpha»,7«beta»,14«alpha»-trihydroxy-5«beta»-cholan-24-oic acid, TMS
|
|
2 | [3184.00; 3188.00] |
| 30-706-4 |
4-O-«beta»-Galactopyranosyl-D-mannopyranose, octakis(trimethylsilyl) ether (isomer 2)
|
|
2 | 2624.80 |
| 30-807-2 |
GA7 di-acid 9,10-ene, methyl ester TMS ether
|
|
2 | 2405.00 |
| 30-831-5 |
4-[2-(4-Allyl-2,6-dimethoxy-phenoxy)-1-hydroxy-propyl]-2-methoxy-phenol, TES
|
|
2 | 3300.00 |
| 30-839-7 |
Sorbopyranose, 1,2,3,4,5-pentakis-O-(trimethylsilyl)-, L-
|
30645-02-4 |
2 | 1854.00 |
| 30-855-9 |
Mannonic acid, 2,3,5,6-tetrakis-O-(trimethylsilyl)-, lactone
|
55515-30-5 |
2 | 2012.00 |
| 30-864-9 |
L-Glutamine, N,N2-bis(tert-butyldimethylsilyl)-, tert-butyldimethylsilyl ester
|
96381-42-9 |
2 | [2406.20; 2431.00] |
| 30-906-2 |
5-Pregnen-3-.beta.,11-.beta.-diol-20-one, MO-TMS
|
|
2 | 2959.00 |
| 30-910-7 |
Nickel, bis[bis(2-methylpropyl)carbamodithioato-S,S']-, (SP-4-1)-
|
15317-78-9 |
2 | 3332.00 |
| 30-947-7 |
5«beta»-cholanoate,3«alpha»,7«alpha»,12«alpha»-trihydroxy, methyl ester-trimethylsilyl ether
|
|
2 | 3225.00 |
| 31-100-5 |
3«alpha»,7«alpha»,12«alpha»-trihydroxy-5«beta»-C29-dioic bile acid, methyl ester, TMS
|
|
2 | 3930.00 |
| 31-392-2 |
d-Glucose, 2,3,4,5,6-pentakis-O-(trimethylsilyl)-, o-methyloxyme, (1Z)-
|
128705-73-7 |
2 | 1882.70 |
| 31-393-1 |
d-Galactose, 2,3,4,5,6-pentakis-O-(trimethylsilyl)-, o-methyloxyme, (1Z)-
|
128705-71-5 |
2 | 1876.30 |
| 31-399-5 |
2,4,6,8,10-Pentamethyl-2,4,6,8,10-pentaphenyl-[1,3,5,7,9,2,4,6,8,10]cyclopentosiloxane
|
|
2 | 3314.00 |
| 31-437-2 |
Silane, diphenyldi(2,2,3,3,4,4,5,5-octafluoropentyloxy)-
|
|
2 | 1877.00 |
| 31-501-0 |
5«alpha»-cholanoate,3«alpha»,7«alpha»,12«alpha»-trihydroxy, methyl ester-trimethylsilyl ether
|
|
2 | 3190.00 |
| 31-514-6 |
3«beta»,7«beta»-Dihydroxy-5«alpha»-androstan-17-one, TMS
|
|
2 | 2798.00 |
| 31-522-7 |
Methyl 7-«alpha»,12«alpha»-dihydroxy-3-keto-4-cholenoate, TMS
|
|
2 | [3345.00; 3346.00] |
| 31-569-6 |
(-)-1,2:5,6-Di-O-cyclohexylidene-L-inositol, bis(trimethylsilyl) ether
|
|
2 | 2567.90 |
| 31-660-4 |
5«beta»-Cholane-3«alpha»,7«alpha»,12«alpha»,24-tetrol, TMS
|
|
2 | 3278.00 |
| 31-663-1 |
Silane, diethyl(2,7-dimethyloct-1-en-3-yn-5-yloxy)nonyloxy-
|
|
2 | 2063.00 |
| 31-712-6 |
3A,17A,20A,21-Tetrahydroxy-5B-pregnan-11-one, tetrakis-TMS
|
|
2 | [3038.00; 3066.00] |
| 31-777-5 |
5«beta»-Cholestane-3«alpha»,7«alpha»,12«alpha»-triol, TMS
|
|
2 | 3195.00 |
| 31-814-3 |
ent-16«beta»,17-H2(OH)2 7«alpha»-OH kaurenolide, MeTMSi
|
|
2 | [2896.00; 2898.00] |
| 31-853-0 |
5-Cholesten-3-«beta»,7-«alpha»,12-«alpha»,24-tetrol, TMS
|
|
2 | 3344.00 |
| 31-951-1 |
17-«alpha»-Hydroxy-7-«alpha»,17-«alpha»-dimethyl-5-«beta»-androstan-3-one, 17-TMS
|
|
2 | 2641.00 |
| 32-009-6 |
*5«beta»-Pregnane-3«alpha», 20«beta»-diol-11-one, MO TMS
|
|
2 | 2886.00 |
| 32-115-8 |
3-«beta»,18-Dihydroxy-5-androsten-17-one, MO TMS
|
|
2 | 2765.00 |
| 32-127-5 |
5-«alpha»-Pregnan-20-«alpha»-ol-11-one, MO-TMS
|
|
2 | 2670.00 |
| 32-143-7 |
D-Glucuronic acid, 2,3,4,5-tetrakis-O-(trimethylsilyl)-, trimethylsilyl ester
|
55530-80-8 |
2 | [2004.00; 2063.00] |
| 32-144-6 |
6-tert-Butyl-2,4-bis(trimethylsilyl)-1,2,4-triazine-3,5-dione
|
|
2 | 1570.00 |
| 32-183-3 |
5-Cholesten-3-«beta»,7-«alpha»,12-«alpha»,25-tetrol, TMS
|
|
2 | 3396.00 |
| 32-213-9 |
Glycine, N-(trimethylsilyl)-N-[3-[(trimethylsilyl)oxy]benzoyl]-, trimethylsilyl ester
|
55517-54-9 |
2 | 2160.00 |
| 32-257-1 |
Methyl 5-.beta.-cholan-3-.alpha.-ol-7-one-24-oate, oxime, TMS
|
|
2 | 3268.00 |
| 32-411-9 |
Isomaltotriose: aD-Glcp(1->6)-aDGlcp(1->6)-DGlc, oxime-TMS, isomer # 2
|
|
2 | [3647.00; 3711.00] |
| 32-422-7 |
D-Glucose, 2,3,4,5,6-pentakis-O-(trimethylsilyl)-
|
6736-97-6 |
2 | [1926.00; 1937.00] |
| 32-650-4 |
Glycine, N-[1-[(tert-butyldimethylsilyl)oxy]propylidene]-, tert-butyldimethylsilyl ester
|
|
2 | 1823.00 |
| 32-789-1 |
L-Cysteine, N,S-bis(tert-butyldimethylsilyl)-, tert-butyldimethylsilyl ester
|
110024-94-7 |
2 | [2189.00; 2215.00] |
| 33-036-5 |
7-Chloro-3-methyl-quinoline-8-carboxylic acid, tert-butyldimethylsilyl ester
|
|
2 | 2310.00 |
| 33-075-2 |
cis-Anthracene, 1,2,3,4-tetrahydro-1,2-diol, methylboronate
|
|
2 | 1960.00 |
| 33-103-0 |
trans-Anthracene, 1,2,3,4-tetrahydro-1,2-diol, bis-TMS
|
|
2 | 2140.00 |
| 33-125-6 |
3-Iodo-L-tyrosine, N,O-bis(trimethylsilyl)-, trimethylsilyl ester
|
|
2 | 2242.10 |
| 33-512-6 |
ent-6«alpha»,7«alpha»,16«alpha»,17-(OH)4 KA, MeTMS
|
|
2 | [2953.00; 2977.00] |
| 33-826-8 |
5«alpha»-Androstane-3«alpha»,16«alpha»,17«beta»-triol, TMS
|
|
2 | 2802.00 |
| 34-040-9 |
5-«beta»-Pregnan-3-«beta»,11-«beta»-diol-20-one, MO-TMS
|
|
2 | 2860.00 |
| 34-113-8 |
3«alpha»,12«alpha»-Dihydroxy-5«beta»-cholanoic acid, methyl ester-trimethylsilyl ether
|
|
2 | 3221.00 |
| 34-237-1 |
3-Methyl-L-histidine, N-(tert-butyldimethylsilyl)-, tert-butyldimethylsilyl ester
|
|
2 | 2347.40 |
| 34-293-9 |
L-(+)-Lactic acid, tert-butyldimethylsilyl ether, tert-butyldimethylsilyl ester
|
|
2 | 1482.00 |
| 34-539-6 |
2-hydroxy-1,4-benzoxazin-3-one, N,O-bistrimethylsilyl
|
|
2 | 1634.00 |
| 34-614-2 |
allo-5B-Pregnan-3A,11B,21-triol-20-one, MO TMS
|
|
2 | [3011.00; 3030.00] |
| 34-631-3 |
5«alpha»-Androstan-17«alpha»-methyl-4«beta»,17«beta»-diol-3,2c-pyrazol, TMS
|
|
2 | [3216.00; 3233.00] |
| 34-680-9 |
2«alpha»,3«alpha»-cyclopropane-5«alpha»-androstan-4.«alpha»,17«beta»-diol, bisTMTBS
|
|
2 | 3930.00 |
| 34-885-2 |
Bolasterone M (5B-Androstan-7A,17A-dimethyl-3A,17B-diol), TMS
|
|
2 | 2725.00 |
| 34-907-7 |
5-«beta»-Pregnan-3-«beta»,11-«beta»,20-«alpha»-triol, TMS
|
|
2 | 2992.00 |
| 34-914-9 |
Silica-1,3,5,8-tetramethyl-2,4,6,7-tetraethylporphyrine complex, bis-OTMS
|
|
2 | 3330.00 |
| 34-939-2 |
4'-Hydroxystanozolol (5A-Androstan-17A-methyl-4',17B-diol-3,2c-pyrazol), TMS
|
|
2 | 3233.00 |
| 35-001-1 |
Silane, dimethyl(2,6-dimethylnon-1-en-3-yn-5-yloxy)dodecyloxy-
|
|
2 | 2264.00 |
| 35-186-7 |
5«beta»-pregnane-3«alpha»,17«alpha»,20«beta»-triol, 3,17,20-tris-TMS
|
|
2 | [2765.00; 2845.00] |
| 35-260-4 |
L-Selenomethionine, N(O,S)-ethoxycarbonyl, (S)-(+)-3-methyl-2-butyl ester
|
|
2 | 1980.20 |
| 35-314-4 |
(3R)-3-Methyl-1,4-bis(trimethylsilyl)piperazine-2,5-dione
|
|
2 | 1372.70 |
| 35-317-1 |
3,16,20-Tris[(trimethylsilyl)oxy]-5.alpha-pregnane, (3«beta»,16«alpha»,20«alpha»)-
|
33287-36-4 |
2 | [3022.00; 3060.00] |
| 35-320-7 |
5-«alpha»-Pregnan-20-«beta»-ol-11-one, MO-TMS
|
|
2 | 2660.00 |
| 35-413-4 |
3«alpha»,5«beta»,12«alpha»-trihydroxy-5«beta»-cholan-24-oic acid, TMS
|
|
2 | [3322.00; 3358.00] |
| 35-419-8 |
2«alpha»,3«alpha»-cyclopropane-5«alpha»-androstan-4.«alpha»,17«alpha»-diol, bisTMTBS
|
|
2 | 3790.00 |
| 35-437-8 |
Silane, diphenyldi(1,1,1-trifluoro-3-bromoprop-2-yloxy)-
|
|
2 | 2097.00 |
| 35-468-4 |
4-Chloro-N-(2-hydroxypropionyl)-benzenesulfonamide, N,O-di(tert.-butyldimethylsilyl)-
|
|
2 | 2563.00 |
| 35-469-3 |
4-Pyridoxic acid, bis(tert-butyldimethylsilyl) ether, tert-butyldimethylsilyl ester
|
|
2 | [2600.90; 2630.00] |
| 35-513-3 |
myo-Inositol, 1,2,3,4,5,6-hexakis-O-(trimethylsilyl)-
|
|
2 | [2073.70; 2153.00] |
| 35-587-2 |
5-Chloro-1H-indole-2-carboxylic acid, tert-butyldimethylsilyl ester
|
|
2 | 2269.00 |
| 35-775-3 |
5.alpha.-Stigmast-8(14)-en-3.beta.-ol, TMS
|
|
2 | 3320.00 |
| 35-781-6 |
Methyl 5-.beta.-cholan-3,12-dione-24-oate, oxime, TMS
|
|
2 | 3324.00 |
| 35-820-2 |
[(2-Ethyl-5-methylfuran-3,4-diyl)bis(oxy)]bis(trimethylsilane)
|
|
2 | 1349.90 |
| 35-843-7 |
5-«alpha»-Pregnan-3-«beta»-ol-11-one, MO-TMS
|
|
2 | 2663.00 |
| 35-880-6 |
cis-Phenanthrene, 9,10-dihydro-9-methyl-9,10-diol, butylboronate
|
|
2 | 2125.00 |
| 35-936-4 |
4-Aminobenzoic acid, N- trifluoroacetyl -, N,O-bis(tert.-butyldimethylsilyl)-
|
|
2 | 2131.00 |
| 35-996-8 |
1,3,5(10)-Oestratriene-2-methoxy-3,16«alpha»,17«beta»-triol, 3-TMS-16,17-PFP
|
|
2 | 2747.00 |
| 36-045-2 |
ent-7-«alpha»,12-«beta»-Dihydroxykaurenonic acid, methyl ester, TMS
|
|
2 | 2562.00 |
| 36-074-0 |
Silane, dimethyl(2,2,3,3,4,4,5,5-octafluoropentyloxy)pentyloxy-
|
|
2 | 1190.00 |
| 36-246-9 |
3«beta»,17«beta»-Dihydroxy-5«alpha»-androstan-6-one, TMS
|
|
2 | 2899.00 |
| 36-280-1 |
[(2-Ethyl-5-methylfuran-3,4-diyl)bis(oxy)]bis[tert-butyl(dimethyl)silane]
|
|
2 | 1801.30 |
| 36-437-7 |
5-«beta»-Pregnan-3-«alpha»20-«beta»-diol-11-one, MO-TMS
|
|
2 | 2906.00 |
| 36-670-8 |
5«alpha»-Androstane-3«beta»,7«alpha»,17«beta»-triol, TMS
|
|
2 | 2692.00 |
| 36-697-9 |
5«alpha»-Androstane-3«alpha»,11«beta»,17«beta»-triol, TMS
|
|
2 | 2743.00 |
| 36-725-7 |
N-(4-Morpholin-4-yl-phenyl)-2-nitro-benzenesulfonamide, N-trimethylsilyl-
|
|
2 | 3236.00 |
| 36-745-5 |
4-Pregnen-3-«beta»,20-«alpha»-diol-11-one, MO-TMS
|
|
2 | 2988.00 |
| 36-790-5 |
tert-Butyl-[2-[2-[2-[2-(tert-butyldimethylsilyl)oxyethoxy]ethoxy]ethoxy]ethoxy]dimethylsilane
|
|
2 | 2207.90 |
| 36-819-3 |
cis-Phenanthrene, 9,10-dihydro-9-methyl-9,10-diol, 3,4-dimethoxy, bis-TMS
|
|
2 | 2440.00 |
| 36-838-2 |
3«alpha»,7«alpha»,12«beta»-Trihydroxy-5«beta»-cholanoic acid, methyl ester-trimethylsilyl ether
|
|
2 | [3240.00; 3268.00] |
| 36-842-7 |
5«alpha»-Androst-16-en-3«beta»-ol trimethylsilyl ether
|
56210-81-2 |
2 | 2245.00 |
| 36-898-6 |
1,1,1-trimethyl-N-((2E)-1-methyl-3-(trimethylsilyl)-4-[(trimethylsilyl)oxy]-1,3-dihydro-2H-imidazol-2-ylidene)silanamine
|
|
2 | [1548.30; 1570.00] |
| 37-022-6 |
5-«beta»-Pregnane-3«beta», 16«alpha», 20«alpha»-triol, MO TMS
|
|
2 | [2872.00; 2906.00] |
| 37-204-4 |
Benzoic acid, 2-hydroxy-5-methyl-3-(1,1-dimethylethyl), DTBS
|
|
2 | 2110.00 |
| 37-309-8 |
2,2,4,4,6,6,8,10-octamethyl-8,10-diphenyl-[1,3,5,7,9,2,4,6,8,10]cyclopentasiloxane
|
|
2 | 2025.00 |
| 37-554-6 |
5-«alpha»-Pregnane-3-«beta»,17-«alpha»,20-«alpha»-triol, tris-TMS
|
|
2 | 2980.00 |
| 37-587-0 |
13,14-Dihydro-15-keto-PGE2, EO-TMS, isomer # 3
|
|
2 | 2825.00 |
| 37-595-1 |
5«alpha»-Androst-1-ene-3,17-dione, per-TMS
|
|
2 | 2643.00 |
|
« Previous Results
Next Results »
|